NCT00893113View on ClinicalTrials.gov

An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Erectile DysfunctionLower Urinary Tract Symptoms
Interventions
DRUG

Placebo

Alfuzosin-matched One tablet once daily

DRUG

Alfuzosin

10 mg once daily

Trial Locations (4)

21061

Chesapeake Urology Research Associates, Glen Burnie

21204

Chesapeake Urology Research Associates, Baltimore

Chesapeake Urology Research Associates, Towson

21237

Chesapeake Urology Research Associates, Baltimore

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Chesapeake Urology Research Associates

OTHER

NCT00893113 - An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms | Biotech Hunter | Biotech Hunter